Close
Back to CVM Stock Lookup

CEL-SCI Corp (CVM) – Hot FDA News

Jun 28, 2021 09:21 AM CEL-SCI Corp (CVM) Multikine Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit in the Group Receiving Surgery Plus Radiotherapy in a Landmark Head and Neck Cancer Phase 3 Study
Jul 24, 2020 08:32 AM CEL-SCI Corp (CVM) Announces Early Results with COVID 19 LEAPS Vaccine/Treatment
Apr 23, 2020 09:17 AM
Mar 9, 2020 07:55 AM
Sep 27, 2016 06:37 AM

Back to CVM Stock Lookup